Implementation of a patient experience–focused review at the time of radiation therapy simulation.

2018 ◽  
Vol 36 (30_suppl) ◽  
pp. 211-211
Author(s):  
John M. Robertson ◽  
Elizabeth Rutka ◽  
Hong Ye

211 Background: Anxiety impairs information retention and may lower patient satisfaction. Because anxiety is highest at the time of radiation therapy (RT) simulation, we added a personal patient experience (PX) review of the treatment process focusing on resolution of any outstanding concerns and measured for a benefit using patient satisfaction scores. Methods: A single PX trained Senior Radiation Therapist met patients at simulation and reviewed multiple factors from registration to any outstanding medical issues, with the goal of addressing and resolving all questions. A CMS-approved patient satisfaction tool was recorded during this time to assess for any benefit of this PX review. The tool asks 17 questions in 5 domains (Registration, Facility, Your Treatment, Personal Issues, and Overall Assessment) and calculates an Overall Facility Rating. Tools received between the date of simulation and the date of follow-up were considered an on-treatment evaluation and were used for assessment. Scores were compared with a Mann-Whitney U test. There were no other formal departmental patient satisfaction efforts during this time. Results: Between 2/16 and 6/18 a total of 1369 patients (median 65 yrs; 64% women; 38% breast cancer; 82% curative) were met at simulation by our Senior Therapist spending a median of 23 minutes per patient (range 0 – 117). We received 732 patient satisfaction surveys (median 67 yrs; 61% women; 40% breast cancer; 90% curative) including 98 on-treatment respondents, 69 of whom had the PX review and reported significantly better scores for 10 of the 17 questions and 4 of the 5 domains (Registration p = 0.04, Facility p = 0.03, Personal Issues p = 0.02, Overall Assessment p = 0.002). The PX review was significantly better for the calculated Overall Facility Rating (p = 0.04). Conclusions: The PX review at simulation was associated with significantly higher patient satisfaction scores in 4 of 5 domains, including areas not specifically addressed during the interview (e.g. cleanliness). Improvements of this amount are typically associated with very large improvements in percentile rankings. This intervention was extremely successful but durability of this benefit into the follow up period was not assessed.

2004 ◽  
Vol 130 (6) ◽  
pp. 327-333 ◽  
Author(s):  
Hans Geinitz ◽  
Frank B. Zimmermann ◽  
Reinhard Thamm ◽  
Monika Keller ◽  
Raymonde Busch ◽  
...  

2021 ◽  
Vol 10 (34) ◽  
pp. 2874-2878
Author(s):  
Anjana Rathan ◽  
Bijulakshmi P. ◽  
Mathumathi S ◽  
Vikram Ramasubramanian ◽  
Kannan M.

BACKGROUND Telemedicine involving teleconsultation has been a boon to people during this pandemic situation. Safeguarding one against the infection should not put people who are in dire need of medical help feel helpless and desperate. Teleconsultation, which was previously used for people who did not have access to medical help due to geographical isolation, has come to the rescue of people during this pandemic, and sometimes it is the only timely help that is available to people in need. We wanted to measure the patient satisfaction level regarding the use of telemedicine for psychiatric and psychological consultations during the Covid-19 pandemic. METHODS The level of patient satisfaction was measured using the patient experience and satisfaction survey’ proposed (The Research and Development Survey-RANDS) (measuring patient experience and satisfaction to telemedicine, 2020) to measure the level of satisfaction to telemedicine during this pandemic situation, regarding the use of telemedicine for patients who consulted doctors and psychologists in a psychiatric hospital in South India. People who participated filled the questionnaire through google form links sent to them. RESULTS The results indicate that 28 % of people who consulted psychiatrists, recorded scores indicating that they were satisfied with the teleconsultation service, while 71 % of people who consulted psychologists reported being highly satisfied with the consultation. This study indicated that some still preferred direct interaction with psychiatrists as evidenced by 72 % of people feeling dissatisfied with teleconsultation. CONCLUSIONS This study shows that with people struggling with mental illness direct interaction is crucial in the treatment process, however, teleconsultation could be used for emergencies to ensure compliance with medication and for monitoring symptoms in patients. KEY WORDS COVID 19, Teleconsultation, Neuro-Psychiatric Hospital, Patient Satisfaction


2020 ◽  
Author(s):  
Vahid Zangouri ◽  
Hamid Nasrollahi ◽  
Ali Taheri ◽  
Majid Akrami ◽  
Peyman Arasteh ◽  
...  

Abstract Background and objective Currently no definite guideline exists on the use of intraoperative radiation therapy (IORT) among patients with early stage BC. We report our experiences with IORT among breast cancer (BC) patients in our region.Methods All patient who received radical IORT from April 2014 on to March 2020 were included in the study. Patient selection criteria were as followed: age equal or older than 45 years old; all cases of invasive carcinomas, moreover in lobular carcinomas only after MRI and confirmation, and in cases with ductal carcinoma in-situ (DCIS) only those with low, intermediate grade, tumor size of equal or less than 2.5cm and a margin of 2-3mm; those between 45 and 50 years old with a tumor size of 0-2cm, those between 50 and 55 years old with a tumor size of 2-2.5cm, and those ≥55 years old with a tumor size of 2.5-3cm; those with invasive tumors a negative margin and in cases of DCIS a margin of 3mm; a negative nodal status (exception in patients with micrometastasis); and a positive estrogen receptor status. Results Overall, 252 patients entered the study. Mean (SD) age of patients was 56.43±7.79 years. In total, 32.9% of patients had a family history of BC. Mean tumor size was 1.56±0.55 cm. Median (IQR) follow-up of patients was 24 (13, 36) months. Overall, 6 patients (2.4%) experienced recurrence in follow-up visits, among which three (1.2%) were local recurrence, two (0.8%) were regional recurrence and one patients (0.4%) had metastasis.Median (IQR) time to recurrence was 23 (13, 36) among the six patient who had recurrence. Overall, 11 patients (4.3%) with DCIS in our study received IORT. All these patients had free margins in histopathology examination. None of these patients experience recurrence.Conclusion For the first time, we categorized patients according to age and tumor size and older patients with larger tumor sizes were considered appropriate candidates for IORT. Our series showed a successful experience with the use of IORT in a region where facilities for IORT are limited using our modified criteria for patient selection.


2021 ◽  
pp. 000313482110474
Author(s):  
Orli Friedman-Eldar ◽  
Christina Layton ◽  
Iago De Castro Silva ◽  
Mecker G Moller ◽  
Ahkeel Allen ◽  
...  

Background For selected patients with early-stage breast cancer (BC), intraoperative radiation therapy (IORT) has emerged as a convenient alternative to standard whole breast irradiation (WBI). We report a single institution experience with IORT in terms of oncologic outcomes, toxicities, and cosmesis. Methods Clinicopathological and perioperative outcomes of patients who underwent IORT for early-stage BC at a public hospital from 2017 to 2020 were retrospectively retrieved. Toxicity was categorized to acute or chronic based on 6 months post-IORT cutoff. Results 85 patients underwent IORT and had complete data, aged 49‐85 years (mean 62). Intraoperative radiation therapy added 23 minutes on average to the total operative time. Final stage was 0, I, and II in 40%, 58.9%, and 1.1% of patients, respectively. Mean tumor size was 0.8 cm (range .1-2.1), with ductal histology comprising 94% of cases. Surgical margins were positive in 2 patients, and adjuvant WBI was required in 5 patients. After a median follow‐up of 17 months (range 3-41), none of the patients had local recurrence and no mortality was recorded. Early wound complications included wound dehiscence (n = 1), seroma/hematoma (n = 15), and re-operation with loss of nipple-areola complex (n = 1). Chronic skin toxicities were reported in 10 (12%) patients and good or excellent cosmetic outcome was reported in 93% of patients. Conclusions Utilizing IORT among low-risk early BC patients may be a safe and more convenient alternative to traditional WBI, with low toxicity rate, acceptable cosmetic results, and good oncologic outcomes at 17 months. Longer follow-up and further prospective controlled studies are needed to confirm these findings.


2021 ◽  
Vol 39 (15_suppl) ◽  
pp. 11036-11036
Author(s):  
Tariqa Ackbarali ◽  
Wendy Turell ◽  
Elizabeth L. del Nido ◽  
Adam Brufsky ◽  
Stephen V. Liu

11036 Background: Improved understanding of the interactions between HER2 and HER3, the heterogeneity of HER-expressing disease, and mechanisms of resistance to anti-HER2 therapy has led to increasing number of treatment options to address clinical needs. Tumor types of interest, impacted by HER2/HER3 expression and pathophysiology were breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, and colorectal cancer (CRC). Increasing competency in these areas is deemed critical to clinician’s ability to individualize treatment plans and improve patient outcomes. Methods: A 2-hour CME activity was broadcast live-online in September 2020 and remains on-demand through September 2021 at OMedLive.com. The educational initiative was divided into one hour addressing HER2 and HER3, testing guidelines, resistance mechanisms and emerging data elucidating recent and ongoing clinical trials across NSCLC, gastric cancer, and CRC. The second hour focused on individualizing metastatic HER2+ breast cancer, HER2-low breast cancer as an emerging subtype, and management of side effects. Knowledge and competence questions were administered pre-, immediate post-, and 2 mos. post-activity. Behavioral impact questions were also asked at follow-up. Data from these questions were analyzed to determine engagement and clinical impact. Results: To date, 448 clinicians participated in the activity. Across the seven CME test questions, improvements in knowledge and competence were observed in the clinical applications of HER2-directed agents and HER3 antibody drug conjugates (ADCs), first-line standard of care for HER2+ breast cancer, and adverse event management for HER2 ADCs. At 2-mos. follow-up, 67% reported improved behavioral impact on both clinical practice and patient experience and outcomes. Clinicians provided specific write-in examples of these changes, noting improved patient-reported outcomes, improved treatment adherence, improved competence developing treatment plans, and increased understanding of HER2/HER3 pathophysiology. Updated and expanded results will be shared. Conclusions: The activity was successful in improving clinician understanding of the relationship between HER2/HER3, pathophysiology across tumor types, and applications of emerging targeted therapies. Open-ended responses to behavioral impact questions illustrated clear improvements in clinician-reported patient experience and outcomes, clinical practice management, and knowledge of emerging HER2/HER3 therapies and their uses across multiple solid tumors.


1998 ◽  
Vol 16 (2) ◽  
pp. 441-452 ◽  
Author(s):  
B Fisher ◽  
J Dignam ◽  
N Wolmark ◽  
E Mamounas ◽  
J Costantino ◽  
...  

PURPOSE In 1993, findings from a National Surgical Adjuvant Breast and Bowel Project (NSABP) trial to evaluate the worth of radiation therapy after lumpectomy concluded that the combination was more beneficial than lumpectomy alone for localized intraductal carcinoma-in-situ (DCIS). This report extends those findings. PATIENTS AND METHODS Women (N = 818) with localized DCIS were randomly assigned to lumpectomy or lumpectomy plus radiation (50 Gy). Tissue was removed so that resected specimen margins were histologically tumor-free. Mean follow-up time was 90 months (range, 67 to 130). Size and method of tumor detection were determined by central clinical, mammographic, and pathologic assessment. Life-table estimates of event-free survival and survival, average annual rates of occurrence for specific events, relative risks for event-specific end points, and cumulative probability of specific events comprising event-free survival are presented. RESULTS The benefit of lumpectomy plus radiation was virtually unchanged between 5 and 8 years of follow-up and was due to a reduction in invasive and noninvasive ipsilateral breast tumors (IBTs). Incidence of locoregional and distant events remained similar in both treatment groups; deaths were only infrequently related to breast cancer. Incidence of noninvasive IBT was reduced from 13.4% to 8.2% (P = .007), and of invasive IBT, from 13.4% to 3.9% (P < .0001). All cohorts benefited from radiation regardless of clinical or mammographic tumor characteristics. CONCLUSION Through 8 years of follow-up, our findings continue to indicate that lumpectomy plus radiation is more beneficial than lumpectomy alone for women with localized, mammographically detected DCIS. When evaluated according to the mammographic characteristics of their DCIS, all groups benefited from radiation.


2018 ◽  
Vol 43 (5) ◽  
pp. 482-487 ◽  
Author(s):  
R Agustín-Panadero ◽  
B Serra-Pastor ◽  
A Fons-Font ◽  
MF Solá-Ruíz

SUMMARY Objectives: To evaluate the clinical behavior of one-piece complete-coverage crowns and fixed partial dentures (FPDs) on teeth with vertical preparation without finish line biologically oriented preparation technique (BOPT). Methods and Materials: This prospective study included 52 patients requiring treatment with restorations in the esthetic region: 74 crowns and 27 FPDs. The sample included a total of 149 teeth that were prepared vertically without finish line. The sample was divided into two groups: one-piece crowns and FPDs, all with zirconia cores, feldspathic ceramic veneer, and a 0.5-mm prosthetic finish line of zirconia. All procedures were carried out at the University of Valencia from 2013 to 2014. The following parameters were evaluated over a two-year follow-up: oral hygiene, periodontal state, gingival thickening, gingival margin stability, the presence of complications, and restoration survival rate. Patient satisfaction with treatment was assessed by means of a visual analogue scale (VAS). Results: Two years after treatment, 80.5% of treated teeth remained free of gingival inflammation and bleeding. Mean gingival thickening was 0.41 ± 0.28 mm for one-piece crowns and 0.38 ± 0.36 mm for FPDs. Gingival margin stability was 100%, but 2% of the sample presented biological complications. The VAS patient satisfaction scores were eight out of a maximum score of 10. Conclusions: Two years after treatment, vertical preparation without finish line produces gingival thickening, margin stability, and optimal esthetics. Neither crowns nor FPDs presented any mechanical complications.


Sign in / Sign up

Export Citation Format

Share Document